Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Danaher/Ormco versus Align Technology

This article was originally published in The Gray Sheet

Executive Summary

Patent suit settlement announced Aug. 17 gives Danaher's Ormco subsidiary a 10% ownership stake in Align Technology, maker of the Invisalign system for treating dental misalignment. Align will give Ormco $13 million in cash as well as company stock worth $77 million under the agreement, pending anti-trust clearance. The settlement also calls for the firms to jointly develop and market an orthodontic product combining Invisalign with Ormco's Insignia custom orthodontic bracket and arch wires system "to treat the most complex cases," Align says. In June, the patent battle resulted in a ruling against Align in the U.S. District Court for the Central District of California (1"The Gray Sheet" July 6, 2009)

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT027810

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel